LU79423A1 - Procede de preparation de compositions pharmaceutiques comprenant un excipient a base de cellulose microcristalline - Google Patents

Procede de preparation de compositions pharmaceutiques comprenant un excipient a base de cellulose microcristalline

Info

Publication number
LU79423A1
LU79423A1 LU79423A LU79423A LU79423A1 LU 79423 A1 LU79423 A1 LU 79423A1 LU 79423 A LU79423 A LU 79423A LU 79423 A LU79423 A LU 79423A LU 79423 A1 LU79423 A1 LU 79423A1
Authority
LU
Luxembourg
Prior art keywords
pharmaceutical compositions
microcrystalline cellulose
compositions containing
preparing pharmaceutical
excipient based
Prior art date
Application number
LU79423A
Other languages
English (en)
French (fr)
Inventor
K Takeo
T Aoyagi
A Tamada
Original Assignee
Fmc Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4154577A external-priority patent/JPS53127553A/ja
Priority claimed from JP8254877A external-priority patent/JPS5420126A/ja
Application filed by Fmc Corp filed Critical Fmc Corp
Publication of LU79423A1 publication Critical patent/LU79423A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU79423A 1977-04-13 1978-04-12 Procede de preparation de compositions pharmaceutiques comprenant un excipient a base de cellulose microcristalline LU79423A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP4154577A JPS53127553A (en) 1977-04-13 1977-04-13 Vehicle
JP8254877A JPS5420126A (en) 1977-07-12 1977-07-12 Pharmaceutical composition

Publications (1)

Publication Number Publication Date
LU79423A1 true LU79423A1 (fr) 1978-11-28

Family

ID=26381183

Family Applications (1)

Application Number Title Priority Date Filing Date
LU79423A LU79423A1 (fr) 1977-04-13 1978-04-12 Procede de preparation de compositions pharmaceutiques comprenant un excipient a base de cellulose microcristalline

Country Status (11)

Country Link
US (1) US4159345A (de)
AU (1) AU508480B2 (de)
DE (1) DE2816055A1 (de)
DK (1) DK159978A (de)
FR (1) FR2387040A1 (de)
GB (1) GB1603533A (de)
IE (1) IE46720B1 (de)
IT (1) IT1095577B (de)
LU (1) LU79423A1 (de)
NL (1) NL7803869A (de)
PH (2) PH14128A (de)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1146866A (en) * 1979-07-05 1983-05-24 Yamanouchi Pharmaceutical Co. Ltd. Process for the production of sustained release pharmaceutical composition of solid medical material
EP0047734A1 (de) * 1980-03-10 1982-03-24 Edward Mendell Co., Inc. Pharmazeutische trägerzusammensetzung und verfahren zu deren herstellung
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
DE69111287T2 (de) * 1990-04-18 1995-12-21 Asahi Chemical Ind Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung.
JP2542122B2 (ja) * 1990-04-18 1996-10-09 旭化成工業株式会社 球状核、球形顆粒およびその製造方法
DE4113044A1 (de) * 1990-10-09 1992-05-21 Degussa Zahnpflegemittel
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
DE4122217C2 (de) * 1991-07-04 1997-02-13 Merz & Co Gmbh & Co Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleinen wirkstoffhaltigen Formkörpern
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
TW260612B (de) * 1993-01-05 1995-10-21 Asahi Chemical Ind
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
IL139728A (en) * 1995-01-09 2003-06-24 Penwest Pharmaceuticals Compan Aqueous slurry composition containing microcrystalline cellulose for preparing a pharmaceutical excipient
US6936277B2 (en) * 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US5665414A (en) * 1995-04-06 1997-09-09 Edward Mendell Co., Inc. Cellulosic materials for incorporation into food products and methods of making same
US5733578A (en) * 1995-11-15 1998-03-31 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6391337B2 (en) 1995-11-15 2002-05-21 Edward Mendell Co., Inc. Directly compressible high load acetaminophen formulations
US6852336B2 (en) 1995-11-15 2005-02-08 J. Rettenmaier & Soehne Gmbh + Co. Kg Directly compressible high load acetaminophen formulations
US6331354B1 (en) 1996-08-23 2001-12-18 Weyerhaeuser Company Alkaline pulp having low average degree of polymerization values and method of producing the same
US6471727B2 (en) 1996-08-23 2002-10-29 Weyerhaeuser Company Lyocell fibers, and compositions for making the same
US6210801B1 (en) 1996-08-23 2001-04-03 Weyerhaeuser Company Lyocell fibers, and compositions for making same
US6306334B1 (en) 1996-08-23 2001-10-23 The Weyerhaeuser Company Process for melt blowing continuous lyocell fibers
JP3718341B2 (ja) * 1998-05-12 2005-11-24 信越化学工業株式会社 低置換度ヒドロキシプロピルセルロースとその製造方法
US6232351B1 (en) 1998-05-22 2001-05-15 Amway Corporation Co-processed botanical plant composition
TW568788B (en) * 1998-10-12 2004-01-01 Chugai Pharmaceutical Co Ltd Polymer combining with phosphoric acid and preparation containing the same
US6773648B2 (en) 1998-11-03 2004-08-10 Weyerhaeuser Company Meltblown process with mechanical attenuation
US7056531B1 (en) * 2000-05-04 2006-06-06 Nature's Way Products, Inc. Sustained release compositions for orally administered substances and methods
JP5110757B2 (ja) * 2000-07-05 2012-12-26 旭化成ケミカルズ株式会社 セルロース粉末
WO2002022172A2 (en) 2000-09-14 2002-03-21 University Of Iowa Research Foundation Powdered/microfibrillated cellulose
US20040043964A1 (en) * 2000-11-06 2004-03-04 Gomi Shun?Apos;Ichi Cellulosic particle for pharmaceuticals preparation
US8071133B2 (en) * 2001-08-20 2011-12-06 Stiefel Laboratories, Inc. Oral dosage forms of water insoluble drugs and methods of making the same
US20040115266A1 (en) * 2002-02-01 2004-06-17 Namburi Ranga Raju Oral itraconazole formulations and methods of making the same
US7638138B2 (en) * 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
AU2003220808B2 (en) 2003-03-27 2008-08-21 Bioactis Limited Powder medicine applicator for nasal cavity
WO2006002419A2 (en) * 2004-06-22 2006-01-05 University Of Iowa Research Foundation Cross-linked cellulose ii
JP4922762B2 (ja) * 2004-08-10 2012-04-25 株式会社新日本科学 速効性でかつ高い吸収性を可能とする経鼻投与用組成物
EP1873196B1 (de) * 2005-04-22 2016-04-13 Asahi Kasei Chemicals Corporation Poröses celluloseaggregat und formzusammensetzung damit
US20080255048A1 (en) * 2005-11-17 2008-10-16 Moise Azria Pharmaceutical Composition
US8106100B2 (en) 2005-12-06 2012-01-31 Asahi Kasei Chemicals Corporation Process for producing tablet by high-speed direct compression
PE20110235A1 (es) 2006-05-04 2011-04-14 Boehringer Ingelheim Int Combinaciones farmaceuticas que comprenden linagliptina y metmorfina
EP1852108A1 (de) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Zusammensetzungen von DPP-IV-Inhibitoren
CA2810839A1 (en) 2006-05-04 2007-11-15 Boehringer Ingelheim International Gmbh A polymorphic form of 1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(r)-amino-piperidin-1-yl)-xanthine
ES2652415T3 (es) 2006-12-26 2018-02-02 Shin Nippon Biomedical Laboratories, Ltd. Preparación para aplicación transnasal
JP5612462B2 (ja) 2007-04-13 2014-10-22 ダウ グローバル テクノロジーズ エルエルシー 剤形用の粒状物質
EP2184056B1 (de) * 2007-08-27 2019-04-24 Asahi Kasei Kabushiki Kaisha Verfahren zur herstellung von tabletten mit kristalliner zellulose und granulaten
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
US9132195B2 (en) * 2008-05-21 2015-09-15 Asahi Kasei Chemicals Corporation Cellulose powder having excellent segregation preventive effect, and compositions thereof
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
SI2400954T1 (sl) 2009-02-27 2017-02-28 Krka, D.D., Novo Mesto Postopek za pripravo trdne oralne dozirne oblike solifenacina in njegovih farmacevtsko sprejemljivih soli
JP2012526726A (ja) * 2009-05-15 2012-11-01 株式会社新日本科学 薬物動態が改善された鼻腔内用薬学的組成物
WO2011013003A2 (en) * 2009-07-31 2011-02-03 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
WO2012138529A1 (en) * 2011-04-06 2012-10-11 Dow Global Technologies Llc Novel polysaccharide derivatives and dosage forms
US9592199B2 (en) 2012-05-31 2017-03-14 Asahi Kasei Chemicals Corporation Cellulose powder
US10016367B2 (en) 2014-08-12 2018-07-10 Asahi Kasei Kabushiki Kaisha Cellulose micropowder
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE621147A (de) *
US3146168A (en) * 1962-04-10 1964-08-25 Fmc Corp Manufacture of pharmaceutical preparations containing cellulose crystallite aggregates
JPS5429566B2 (de) * 1974-09-13 1979-09-25
JPS5132719A (en) * 1974-09-13 1976-03-19 Yoshinobu Nakai Iyakuhinnoshorihoho

Also Published As

Publication number Publication date
DK159978A (da) 1978-10-14
IE46720B1 (en) 1983-09-07
US4159345A (en) 1979-06-26
IT7822237A0 (it) 1978-04-12
AU3279578A (en) 1979-08-02
IT1095577B (it) 1985-08-10
AU508480B2 (en) 1980-03-20
IE780729L (en) 1978-10-13
GB1603533A (en) 1981-11-25
DE2816055A1 (de) 1978-10-26
NL7803869A (nl) 1978-10-17
FR2387040B1 (de) 1983-01-28
FR2387040A1 (fr) 1978-11-10
PH14128A (en) 1981-02-26
PH15398A (en) 1982-12-23

Similar Documents

Publication Publication Date Title
LU79423A1 (fr) Procede de preparation de compositions pharmaceutiques comprenant un excipient a base de cellulose microcristalline
IT1109273B (it) Procedimento per preparare composizioni farmaceutiche a base di amossicillina
BE863883A (fr) Procede de preparation de derives de la pyrrolidine
BE867326A (fr) Procede de preparation de 1,2-polybutadiene
BE851788A (fr) Procede de preparation de copolymeres solubles
PT64907B (fr) Procede de preparation d'une formulation a activite retarde
BE861112A (fr) Procede de preparation de 2-nitrate de 1,4:3,6-dianhydro-d-glucitol
FR2282455A1 (fr) Procede de preparation de pigments a base de phtalocyanine
BE865661A (fr) Procede de preparation de 3-alkyl-butene-1-als
LU80459A1 (fr) Procede de preparation de compositions tensio-actives cationiques
ES487487A0 (es) Un procedimiento de preparacion de un derivado de tetrahidrofurano
PT76853B (fr) Procede de preparation de compositions pharmaceutiques a base de xylosides et lyxosides de base puriques et pyrimidiques
BE865201A (fr) Procede de preparation de 1-amino-3-aryloxy-2-propanols
ZA785628B (en) New imidazobenzoxazines and their salts,process for their preparation and pharmaceutical compositions
BE870162A (fr) Procede de preparation de p-benzoquinonediacetals
BE864280A (fr) Procede de preparation de m-bromo-alpha,alpha, alpha,-trifluorotoluenes
FR2330765A1 (fr) Composition comprimee a base de levure et procede de sa preparation
RO75382A (ro) Procedeu de preparare a compusilor 1-alogen-1-propin-3-oil
FR2322848A1 (fr) Procede de preparation d'un ester cyclopropane-carboxylique
FR2325692A1 (fr) Procede de preparation de poudres de poly(amide-imides)
GB1545629A (en) Process for preparing diaminodikto-,diaminodihydroxy-aminohydroxydiketo-,dihydroxyketimino-and diketo dihydroxy-hydronaphthacene derivatives
PT68138A (fr) Procede de preparation de methoxy-2 benzamides
SE7803456L (sv) Forfarande for framstellning av en farmaceutisk komposition
LU80262A1 (fr) Procede de preparation de 10,11-dihydro-5h-dibenzo(a,d)cycloheptene-5,10-imines substituees en position 5
HU179217B (en) Process for preparing a pharmaceutical composition for sensibilisation